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Non-canonical Wnt signalling regulates scarring in
biliary disease via the planar cell polarity receptors
D.H. Wilson 1, E.J. Jarman 1, R.P. Mellin 1,14, M.L. Wilson1, S.H. Waddell1, P. Tsokkou 1, N.T. Younger 1,
A. Raven2, S.R. Bhalla3, A.T.R. Noll4, S.W. Olde Damink4,5, F.G. Schaap4,5, P. Chen6, D.O. Bates3,7, J.M. Banales8,
C.H. Dean 9, D.J. Henderson10, O.J. Sansom 2,11, T.J. Kendall 12,13 & L. Boulter 1*
The number of patients diagnosed with chronic bile duct disease is increasing and in most
cases these diseases result in chronic ductular scarring, necessitating liver transplantation.
The formation of ductular scaring affects liver function; however, scar-generating portal
fibroblasts also provide important instructive signals to promote the proliferation and dif-
ferentiation of biliary epithelial cells. Therefore, understanding whether we can reduce scar
formation while maintaining a pro-regenerative microenvironment will be essential in
developing treatments for biliary disease. Here, we describe how regenerating biliary epi-
thelial cells express Wnt-Planar Cell Polarity signalling components following bile duct injury
and promote the formation of ductular scars by upregulating pro-fibrogenic cytokines and
positively regulating collagen-deposition. Inhibiting the production of Wnt-ligands reduces
the amount of scar formed around the bile duct, without reducing the development of the
pro-regenerative microenvironment required for ductular regeneration, demonstrating that
scarring and regeneration can be uncoupled in adult biliary disease and regeneration.
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Introduction: Biliary diseases, also known as cholangiopathies,account for approximately one-third of all adult liver diseaseand 70% of childhood liver disease1. Chronic damage to the
bile duct typifies biliary disease and results in the proliferation of
biliary epithelial cells (BECs) and the formation of a regenerative
microenvironment populated by immune cells and fibroblasts2.
These cells provide both instructive signals to BECs3,4 and
maintain tissue integrity by depositing scar tissue5–7, thereby
promoting bile duct regeneration. It remains unclear whether
BECs communicate to the microenvironment to maintain it
appropriately and regulate the amount of extracellular matrix
(ECM) that is deposited by surrounding cells.
In a number of tissues, epithelial regeneration relies on the
activation of Wnt-β-catenin signalling by locally produced Wnt
ligands8–10, and previous studies have concluded that BEC pro-
liferation is β-catenin dependent11,12. Recent advances in both
animal models13 and single-cell RNA sequencing however, have
challenged the central role for Wnt-β-catenin signalling in BEC
proliferation and have suggested that the role of Wnt in these
processes could be more complex than previously thought14,15. In
addition to stabilising β-catenin, Wnt ligands integrate into a
much larger signalling network, thereby activating a number of
Wnt-dependent signalling cascades16,17. These, so-called, non-
canonical Wnt signalling pathways are highly conserved from
Drosophila through to vertebrates and utilise a broad range of cell
surface receptors to activate diverse downstream processes18–20.
Wnt-Planar Cell Polarity (Wnt-PCP) signalling represents one of
these non-canonical pathways and is required for a number of
morphogenic processes in the embryo;21,22 moreover, Wnt-PCP
signalling has been implicated in the pathogenesis of a number of
adult diseases and cancers23–25. Whether Wnt-PCP signalling
plays a role in bile duct disease and regeneration has not been
determined.
Here, we demonstrate that Wnt ligands associated with non-
canonical Wnt signalling, particularly Wnt5a26, are upregulated
in biliary injury. In this context, therapeutic inhibition of the Wnt
signalling pathway, through the prevention of Wnt-ligand
secretion, reduces the level of fibrosis deposited around pro-
liferating BECs, without affecting BEC number. We then go on to
demonstrate that Wnt ligands regulate this process through
Planar Cell Polarity receptors that activate the JNK/c-JUN sig-
nalling pathway specifically in BECs. In turn, this Wnt-PCP
signal promotes BEC crosstalk with portal fibroblasts and reg-
ulates the capacity of fibroblasts to synthesise collagen and form
scar tissue. This study demonstrates how non-canonical Wnt
signalling functions to regulate adult tissue scarring by integrating
a number of cell types and offers a novel therapeutic target to
treat biliary diseases in patients.
Results
Wnt-PCP signalling is activated during duct regeneration. BEC
proliferation is required during bile duct regeneration;27 however,
the role that Wnt signalling plays in this process remains con-
troversial, with conflicting reports describing variable roles for
Wnt-β-catenin13,14,28. Using tissue from patients with primary
sclerosing cholangitis (PSC), a progressive human biliary disease
in which BECs proliferate29 and also two mouse models of BEC
proliferation (thioacetamide, TAA or 3,5-diethoxycarbonyl-1,4-
dihydrocollidine, DDC30,31) we sought to determine whether the
Wnt-β-catenin pathway is activated in BECs. To do this, we
assessed Axin2 mRNA expression and the nuclear translocation
of β-catenin in BECs. We failed to see that β-catenin translocates
into the nucleus of BECs nor did we see the expected increase in
Axin2 expression in any of these contexts (Supplementary Fig. 1).
Despite seeing no changes in these models, we have found that as
in many other systems32,33 Axin2 mRNA expression is responsive
to changes in canonical Wnt signalling in BECs. In both mouse
and human BECs, Axin2 mRNA is increased following β-catenin
stabilisation using a GSK3β inhibitor, CHIR99021, and decreases
when β-catenin-dependent transcription is inhibited by PRI72434
(Supplementary Fig. 1a). Therefore, our data suggest that whilst
the Wnt-β-catenin pathway can be activated pharmacologically in
BECs, activation of this pathway does not increase in BECs
during bile duct regeneration. These data are in concordance with
recent work showing that BECs do not express LGR proteins
necessary for Wnt signalling potentiation14,35, and that LRP-
dependent Wnt signalling is dispensable for BEC organoid
growth in vitro36. (We discuss these data in more detail in
the Supplementary Discussion).
In addition to activating Wnt-β-catenin signalling, Wnt ligands
also act via an alternative Wnt pathway known as Wnt-PCP
signalling, which, through the activation of Rho-GTPases and
JNK/c-JUN19,37, promotes ductular formation in a number of
embryonic contexts21,38. In liver tissue from patients with PSC,
the number of BECs with phosphorylated JNK (phospho-
JNKT183/Y185) is significantly increased, and while c-JUN is
expressed broadly within BECs, c-JUN phosphorylation (phos-
pho-c-JUNS73) is increased in PSC patients compared with those
without disease (Fig. 1a, b), indicating that in ductular
regeneration, the Wnt-PCP signalling pathway is likely activated.
Native liver explants from patients with PSC are severely
fibrotic/cirrhotic and so represent end-stage disease. Therefore, it
is not possible to determine whether Jnk/c-Jun signalling is
dynamically regulated during disease progression. To characterise
this, we evaluated the expression of phospho-JnkT183/Y185 and
phospho-c-JUNS73 during regeneration in two models of biliary
injury and BEC proliferation and found that the number of
phospho-JNKT183/Y185 and phospho-c-JUNS73 positive biliary
cells is significantly increased compared with uninjured bile ducts
(Fig. 1c, d). Furthermore, in isolated bile ducts from mice with
biliary disease, matrix metalloproteinase-7 (Mmp7) and con-
nective tissue growth factor (Ctgf), known c-JUN target genes39,
which are associated with biliary scarring40,41, are also tran-
scriptionally upregulated (Fig. 1e) and localise to BECs
specifically (Fig. 1f, positive and negative RNAscope controls,
supplementary Fig. 1h).
Wnt–Jnk/c-Jun regulates biliary scar formation. Previous stu-
dies have found that loss of Wnt-ligand secretion following Wnt-
less (Wls) deletion alters biliary regeneration and fibrosis13,42,43.
However, recent data suggesting that these ligands are not
functioning though a Wnt-β-catenin pathway in BECs13,14, led us
to hypothesise that Wnt ligands activate Wnt-PCP signalling in
bile ducts. To validate that Wnt ligands were upregulated in
response to injury, we evaluated the mRNA expression of all Wnt
ligands in isolated bile ducts from both the DDC and TAA
models (Supplementary Fig. 2), thereby identifying a number of
ligands that were transcriptionally overexpressed compared with
healthy ducts. To resolve whether Wnt ligands are activating a
Wnt-PCP signalling pathway during biliary repair, wild-type mice
with biliary injury were given LGK97444, a highly selective inhi-
bitor of the MBOAT acyltransferase, Porcupine, which is required
to add lipid modifications to Wnt ligands (LGK974 from hereon
is referred to as Porcupine-i). Inhibition of Porcupine results in
the global suppression of Wnt-ligand secretion and renders Wnt
ligands unable to bind to the CRD domain of Frizzled. Our
experimental strategy is summarised in Fig. 2a.
Following administration of Porcupine-i during biliary regenera-
tion, isolated bile ducts had a reduced transcriptional expression
of Ctgf and Mmp7 (Fig. 2b). However, Wnt-β-catenin target genes
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including Axin2 were not changed following Porcupine inhibition
(Supplementary Fig. 3a). There was an obvious reduction in
glutamine synthetase (GS) positivity, a known target of Wnt-β-
catenin signalling in hepatocytes (Supplementary Fig. 3b), con-
firming that Wnt-ligand inhibition across the liver had been
successful. In proliferating BECs (in both the TAA and DDC
models) Porcupine-i results in a significant reduction in phospho-
JNKT183/Y185 and phospho-c-JUNS73 positivity, indicating that in
biliary epithelial cells the activation of Jnk/c-Jun signalling is, in
part, regulated by Wnt ligands (Fig. 2c).
Having defined that Porcupine-i alters Jnk/c-Jun signalling in
BECs we sought to then determine whether the inhibition of
Wnt-ligand secretion affects the regeneration of the biliary tree.
Whilst the number of BECs (stained for Keratin-19) and
fibroblasts (stained for Desmin) remained the same between
Porcupine-i and control mice (Fig. 2d), the amount of total
fibrillar collagen (determined through staining for Picrosirius
Red) and specifically Collagen-1 that is deposited during bile duct
regeneration is significantly reduced following Porcupine inhibi-
tion (Fig. 2d).
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Fig. 1 Activation of the Jnk–Jun signal in biliary disease. a Immunohistochemistry on serial sections of either non-diseased (upper panels) or primary
sclerosing cholangitis tissue (bottom panels) stained for phosphorylated JNKT183/Y185, total c-JUN and phosphorylated c-JUNS73. Dotted lines demarcate
the boundary of bile ducts. Red arrows identify biliary epithelial cells with positive phosphorylated c-JUNS73 expression. b Quantification of phosphorylated
JNKT183/Y185, total c-JUN or phosphorylated c-JUNS73 and the quantification of c-JUN:phospho-c-JUNS73 in normal human and primary sclerosing
cholangitis tissue. c Immunohistochemistry of phosphorylated JNKT183/Y185, total c-JUN and phosphorylated c-JUNS73 in a time course of DDC injury to
model fibrotic initiation or in established fibrosis induced by treatment with TAA. Red arrows denote positive nuclei. Dotted lines demarcate biliary
epithelial cells and bile ducts. d Quantification of phosphorylated JNKT183/185, total c-JUN, phosphorylated c-JUNS73 and the ratio of total c-JUN:
phosphorylated c-JUNS73 in the DDC and TAA models. e mRNA expression of Wnt-PCP target genes in mice undergoing DDC and TAA-induced biliary
injury, normalised to the housekeeping gene, Ppia. f RNAScope of mRNA for Ctgf and Mmp7 in healthy bile ducts and following bile duct injury. Red arrows
denote RNAScope positivity. Scale bar= 50 µm. p.v.—portal vein, b.d.—bile duct. Porphyrin (labelled) accumulation in the duct is a consequence of the
DDC model. Source data are provided as a Source Data file. In graphs where two groups are included, a Student’s t test is used. When comparing multiple
groups, a one-way ANOVA with post hoc correction for multiple testing is used. In dot plots, data are presented as mean ± S.E.M. Each data point (N)
represents an individual animal or patient.
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Given that the inhibition of Wnt-ligand secretion is sufficient
to alter Jnk/c-Jun signalling and regulate biliary fibrosis, we then
sought to define the origin of the Wnt ligands involved in this
process. Previous work from our lab and others has shown that
myeloid cells (including macrophages) are a source of multiple
Wnt ligands3,9,45, including the archetypal Wnt-PCP ligand,
Wnt5a46, and indeed, in CD45+/CD11b+ macrophages isolated
from the livers of mice with biliary injury, we found that
macrophages expressed WNT5A. Moreover, in macrophages
from mice treated with porcupine-i, 50% of cells retained
WNT5A in their ER compared with 32% in vehicle-treated
animals (Supplementary Fig. 3c-f). WNT5A is transcriptionally
upregulated in liver patients with PSC compared with livers from
patients without underlying disease (Supplementary Fig. 4a), and
similarly, in mouse models of biliary regeneration Wnt5a
transcript expression is induced following injury (Fig. 3a). In
these murine models of bile duct regeneration and BEC
proliferation, CD68-positive macrophages, but not Desmin-
positive myofibroblasts, in close proximity to BECs express
Wnt5a mRNA (Supplementary Fig. 4c) and WNT5A protein47
(Fig. 3b). Moreover, in PSC patient tissues WNT5A-positive cells
localise to the scars surrounding the bile duct (Supplementary
Fig. 4b), suggesting that the provision of Wnt ligand by
macrophages could promote biliary fibrosis.
To understand whether Wnt5a-expressing myeloid cells
regulate biliary scarring, we made use of a mouse line in
which Cre recombinase is expressed by myeloid lineages to
delete Wnt5a specifically in these cells (LysMCre::Wnt5aflox,
a
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Fig. 2 Therapeutic inhibition of Wnt reduces scarring. a Schematic of Porcupine inhibition with Porcupine-i during bile duct regeneration induced by DDC
or TAA. b mRNA expression of Wnt-PCP pathway target genes Ctgf and Mmp7 in isolated bile ducts following Porcupine-i treatment, normalised to the
housekeeping gene Ppia. c Immunofluorescent staining of biliary epithelial cells (Keratin-19-positive, red) with phosphorylated JNKT183/Y185 (upper panels)
or phosphorylated c-JUNS73 (lower panels), green. White arrows denote positivity in biliary epithelial cells, yellow arrows show positivity in other, non-
keratin-19-positive cells. Positivity of phosphorylated JNKT183/Y185 and phosphorylated c-JUNS73 quantified in dot plots and represented as a proportion of
total biliary epithelial cells counted. d Histological quantification of Keratin-19 (biliary epithelial cells), Desmin (fibroblasts), Picrosirius Red, PSR (fibrilar
collagens) and Collagen-1 in livers of mice treated with either DDC or TAA, following Porcupine inhibition. Scale bar= 50 µm. p.v.—portal vein, b.d.—bile
duct. Source data are provided as a Source Data file. In all comparisons, a Student’s t test is used. Box–whisker plots represent min–max range of the data.
In dot plots, data are presented as mean ± S.E.M. Each data point (N) represents an individual animal.
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Supplementary Fig. 4d–g). Following biliary injury with either
DDC or TAA, isolated bile ducts showed a reduced mRNA
expression of Ctgf and Mmp7 when myeloid Wnt5a was deleted
compared with ducts isolated from mice in which Wnt5a was
intact (Fig. 3c, e), but did not show changes in Wnt-β-catenin
pathway target expression (Supplementary Fig. 4h). Moreover, in
both models of bile duct regeneration, the amount of PSR staining
and Collagen-1 immunostaining was significantly reduced follow-
ing Wnt5a deletion in myeloid cells, without affecting the number
of keratin-19-positive BECs or Desmin-positive myofibroblasts
(Fig. 3d, f). Interestingly, in our acute (DDC) model of biliary
regeneration, high Wnt5a expression does not persist throughout
injury. When Wnt5a is deleted from myeloid cells specifically at
later time points in this model, the changes in Collagen-1 and PSR
are lost, suggesting that either Wnt5a is only required for the
initiation of ductular fibrosis in this context or that other Wnt
ligands or signalling pathways compensate for Wnt5a loss in
myeloid cells.
Wnt-PCP receptors regulate ductular scarring. There is a high
level of redundancy within the Wnt-ligand family48 and con-
flicting data as to whether Wnt ligands are faithful activators of
particular downstream receptors. Therefore, we sought to validate
our findings that Wnt ligands and particularly Wnt5a regulate
biliary scarring through Wnt-PCP activation. In Wnt-PCP sig-
nalling a number of receptors, including Frizzled receptors49 and
orphan receptor tyrosine kinases such as ROR1/2 and PTK7 are
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known to bind Wnt ligands50. These then converge on the scaf-
folding proteins VANGL1 and VANGL2, which become phos-
phorylated51, a process that is necessary for Wnt-PCP activity.
VANGL1 and VANGL2 are transcriptionally upregulated in PSC
patients (Fig. 4a and Supplementary Fig. 5a). Moreover, in PSC
patients, VANGL2 and PTK7 proteins localise to the plasma
membranes of proliferating BECs (Fig. 4b), but not in healthy bile
ducts suggesting that upregulation of Wnt-PCP pathway com-
ponents occurs in biliary disease.
As Vangl2 is functionally dominant over its homologue
Vangl152, we elected to study whether Wnt signalling via Vangl2
regulates the formation of biliary scars. Similar to human, healthy
mouse bile ducts express low levels of Vangl1 and Vangl2 at the
transcriptional level, and positive staining for VANGL1/2
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proteins in the plasma membranes of BECs is infrequent
(Fig. 4c–e and Supplementary Fig. 5b). Similarly, in healthy
BECs, Ptk7 expression is low, although PTK7-positive portal
fibroblasts can be seen surrounding healthy ducts (Fig. 4e).
Following bile duct injury with either DDC or TAA, Vangl2 and
Ptk7 mRNA levels increase in isolated bile ducts (Fig. 4e and
Supplementary Fig. 5b), and VANGL2 and PTK7 proteins co-
localise on the plasma membrane of BECs specifically (Fig. 4e,
lower panels).
Wnt-PCP signalling can be effectively inhibited through
modulating Vangl2 activity using a semi-dominant hypomorphic
Vangl2 mutant, Vangl2S464N, also known as Looptail22. Mice
homozygous for this mutation die shortly after birth; however,
heterozygous mice (Vangl2S464N/+, hereafter denoted as
Vangl2S464N) are viable, reach adulthood and have been used to
determine the role of Vangl2 in a number of adult contexts53. In
isolated bile ducts from Vangl2S464N mice given either DDC or
TAA injury (Fig. 5a), we found a significant reduction in the
mRNA expression of Mmp7 and Ctgf (Fig. 5b, c), indicating that
in both short-term and long-term fibrotic injury, signalling
downstream of BEC-expressed VANGL2 regulates Ctgf and
Mmp7 levels. Having shown that mutations in Vangl2 phenocopy
the transcriptional changes seen with Porcupine inhibition (Fig. 2)
we sought to define whether mice carrying the Vangl2S464N
mutation had a reduced ability to form bile duct scars following
injury. Following DDC or TAA injury, mice with wild-type
Vangl2 developed progressive ductular fibrosis. In littermates that
carried a heterozygous mutation, however, the level of scarring
was significantly reduced (Fig. 5d). Interestingly, mutations in
Vangl2 did not affect the number of BECs (Fig. 5e), nor did
reduced VANGL2 function result in changes in the number of
Desmin-positive fibroblasts (Fig. 5f) found within the liver. In
concordance with the mRNA expression (Fig. 5b, c), the levels of
CTGF protein were significantly reduced in Vangl2S464N mice
following bile duct injury compared with control littermates
(Fig. 5g). Given that the Vangl2S464N mutant mouse phenocopies
Wnt-ligand loss following Porcupine inhibition, we suggest that
Wnt-PCP signalling is required for the establishment of biliary
scars in the mouse.
The Vangl2S464N mutation is constitutive, and therefore we
could not preclude that there were developmental deficiencies
in bile duct development and patterning, which are simply
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Fig. 5 Inhibition of Wnt-PCP reduces the formation of biliary scars. a Schematic representing the treatment strategy of Vangl2S464N mutant mice treated
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TAA-induced biliary regeneration normalised to Ppia. d Image quantification of Picrosirius Red, PSR (fibrillar collagen) and Collagen-1 in DDC or TAA-
induced biliary injury. e Quantification of the number of BECs (through Keratin-19 immunohistochemistry) following DDC (left panel) or TAA (right panel)
in Vangl2S464N mutant mice compared with controls. f Desmin positivity (fibroblasts) in mice with DDC or TAA-induced biliary regeneration. g Image
analysis and quantification of CTGF protein levels in mice with DDC (upper panel) or TAA- (bottom panel) induced biliary injury. Source data are provided
as a Source Data file. In graphs where two groups are included, a Student’s t test is used. When comparing multiple groups, a two-way ANOVA with post
hoc correction for multiple testing is used. Box–whisker plots represent min–max range of the data. In dot plots, data are presented as mean ± S.E.M. Each
data point (N) represents an individual animal.
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exacerbated during ductular regeneration. To overcome this, we
utilised a transgenic mouse line in which Vangl2 can be
specifically deleted in cells (Vangl2flox)54.
To confirm that Vangl2 can be deleted in the BEC lineage, we
isolated bile ducts from Vangl2flox/flox mice or wild-type
littermates and grew these as organoids (Fig. 6a). Following
infection with lentiviral-Cre (Lv-Cre), BECs in these organoids
recombine floxed alleles in a mosaic way (Supplementary Fig. 6a).
However, recombined cells can be enriched and produce
relatively pure organoid cultures. BEC organoids derived from
Vangl2flox/flox mice grow normally following expression of Cre,
however they have significantly reduced Vangl2 mRNA expres-
sion (Supplementary Fig. 6b). Furthermore, VANGL2 protein
levels are reduced and VANGL2 no longer localises to the plasma
membrane of BECs in these organoids (Fig. 6a, b, from herein
these organoids are known as Vangl2ΔTM). Following Vangl2
loss, Vangl2ΔTM organoids show reduced levels of nuclear
phospho-c-JUNS73 (Fig. 6a, lower panels), and whilst the levels
of total JNK and c-JUN remain unchanged in Vangl2WT versus
Vangl2ΔTM organoids, BECs in organoids lacking Vangl2 have
notably reduced levels of phosphorylated JNKT183/Y185 and have
a 40% reduction of phosphorylated c-JUNS73 (Fig. 6b). Further-
more, VANGL2 loss significantly reduces the mRNA levels of
Mmp7 and Ctgf (Fig. 6c), confirming that the levels of these
transcripts relate to signalling through Vangl2.
Having confirmed that Vangl2-specific deletion in BECs alters
Wnt-PCP signalling in vitro, we generated a mouse in which
Vangl2 could be specifically deleted in BECs following admin-
istration of tamoxifen (K-19CreERT::Vangl2flox). In K-19CreERT::
Vangl2flox mice, following injury, we failed to detect phospho-
JNKT183/Y185 or phospho-c-JUNS73 in Vangl2ΔTM BECs (Fig. 6d).
Importantly, Vangl2ΔTM cells (lineage traced with RFP) are
retained in vivo in the bile duct following injury (Supplementary
Fig. 6c and d), indicating that Vangl2 is not an essential gene for
BEC survival. Yet, following Vangl2 deletion, the amount of
Mmp7 and Ctgf mRNA in isolated bile ducts and CTGF protein
was significantly reduced (Fig. 6e, f). Moreover, the levels of total
fibrillar collagen assessed through Picrosirius Red staining and
Collagen-1 specifically, surrounding these Vangl2ΔTM BECs, were
also reduced (Fig. 6g) without affecting the number of portal
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fibroblasts (Fig. 6h), confirming that lineage-specific deletion of
Vangl2 in BECs is sufficient to reduce biliary scarring and
validating the phenotype found using Vangl2S464N mutant mice.
Discussion
Canonical Wnt-β-catenin signalling is widely regarded as a
principal regulator of the cell cycle in adult tissue homoeostasis55
and regeneration35, where the stabilisation of β-catenin and its
translocation into the nucleus promotes the transcription of a
number of pro-proliferative and pro-survival pathways in a ple-
thora of tissues. In the context of cancers too, the role of Wnt-β-
catenin has been widely and extensively studied45,56 as mutations
in β-catenin and in its hallmark regulators APC and Axin pro-
mote deregulated cell proliferation and are now considered
oncogenes in a wide array of contexts1,57,58.
Wnt ligands do however, act through a number of highly
conserved developmental pathways59, which likely evolved to
regulate the formation of the anterior–posterior axis in the ear-
liest multicellular organisms, and establish polarity in groups of
cells60,61. This pathway, the Wnt-Planar Cell Polarity (Wnt-PCP)
pathway, is necessary for establishing any number of axes within
the embryo, and through its control of cell shape, migration and
planar cell movement is absolutely required for normal organo-
genesis38,62,63. The role of Wnt ligands in establishing these body
plans likely predates their role in activating β-catenin-dependent
transcription, yet whether Wnt-PCP signalling plays a role in
adult homoeostasis and regeneration remains largely mysterious,
and work unpicking the role of Wnt-PCP in adult disease and
tissue regeneration remains in its infancy.
The bile duct, like other epithelial structures in the liver, has a
remarkable regenerative capability, and following injury, biliary
epithelial cells (BECs) begin to proliferate and form new tubular
networks, ultimately restoring flow though the duct and main-
taining the function of the liver27. The role of Wnt signalling in
the context of BEC proliferation and bile duct regeneration has
been contested, with a number of early papers demonstrating
activation of the canonical, Wnt-β-catenin-dependent pathway in
these cells11,28. Whether Wnt-β-catenin is as important as these
early papers suggested remains contentious, as we and others
have failed to find nuclear translocation of β-catenin or activation
of canonical Wnt-β-catenin receptors in BECs during bile duct
regeneration3,35. Furthermore, recent studies using single-cell
RNA (scRNA) sequencing have failed to find an obvious cano-
nical Wnt signature in BECs14,15, and deletion of the Wnt-
potentiating R-Spondin (RSPO)-LGR system in BECs had little
effect on their proliferation14. These data are not unequivocal, as
recent work has indicated that RSPO can function independently
of LGR proteins64. Though if this is the case in BECs they would
stand out as unusual as the majority of Wnt-responsive cells in
the adult have been shown to require the RSPO-LGR rheo-
stat35,55,65. Several papers have now suggested that Notch and
Yap signalling, not canonical Wnt signalling, are the favoured
routes to promote BEC proliferation3,14,15,66. Our data presented
here are in agreement with this observation; however, whereas
other groups fail to see Axin2 transcripts in BECs14,15, we find
infrequent transcripts that do not increase with injury, and
therefore we conclude that canonical Wnt-β-catenin signalling is
not upregulated in patients with biliary disease or animal models.
There is little doubt that Wnt ligands are expressed during
biliary regeneration3,13,15,28, and from our data in this paper and
those data from other groups it appears that in the context of bile
duct injury and repair at least that myeloid-derived Wnts play an
important role in regulating this process42,43. Importantly, others
have shown that BEC proliferation is dependent on Wnt ligands,
but that this proliferation in BECs is β-catenin independent,
suggesting that non-canonical Wnt signalling pathways, including
but not limited to Wnt-PCP, regulate cholangiocyte prolifera-
tion13. In this study, we repeatedly fail to see a reduction in
cholangiocyte number when we inhibit Wnt-PCP signalling, as
would be expected based on previous data13. We cannot exclude,
however, the possibility that there are compensatory pro-
proliferative mechanisms that take place following pharmacolo-
gical inhibition of Wnt-ligand production, nor can we exclude the
possibility that BEC proliferation is driven through a non-
canonical or atypical Wnt pathway that does not depend on
Vangl2, such as Wnt-STOP or Wnt-YAP/TAZ signalling67,68.
In this study, we do, however, find a consistent and repro-
ducible suppression of bile duct fibrosis when Wnt-PCP signal-
ling is inhibited in BECs. In this model, the binding of Wnt
ligands, through Wnt-PCP receptor activation, including Ptk7
and Vangl2, results in the phosphorylation of Jnk, which pro-
motes c-Jun-dependent transcription. These observations are
concordant with scRNA data in which the AP-1 transcription
factor network is enriched in BECs15. Inhibition of Wnt ligands,
either genetically or using a therapeutic Wnt inhibitor, sig-
nificantly decreases the amount of biliary scarring that occurs
following injury, leading us to demonstrate that Wnt-PCP sig-
nalling is upstream of fibrogenic cytokine production. Surpris-
ingly, heterozygous loss of Vangl2, through the Vangl2S464N
mutation, is sufficient to reduce biliary scarring, suggesting that
this system requires tight regulation. Emerging data from other
chronically diseased tissues indicate that Wnt-PCP signalling can
play a role in the establishment and maintenance of scarring and
deposition of the extracellular matrix20,53,69,70; here we show that
Wnt-PCP is also involved in the formation of biliary scars in the
adult liver.
Adult tissue repair, by its very nature, requires fine balance
between epithelial regeneration and scarring. While fibroblasts in
the regenerative microenvironment are the primary cells that
make scar tissue, we and others have previously shown that the
fibroblast microenvironment in biliary regeneration provides a
number of signals that BECs require to maintain both their pro-
liferation and lineage specification3,4,66. Deleting these pro-
fibrogenic cells or inhibiting their activation/proliferation would
therefore have significant consequences for the regenerating bili-
ary epithelium and could ultimately prevent ductular regrowth
following injury. Inhibition of Wnt signalling or loss of Wnt-PCP
receptors on proliferating BECs does not affect the formation of
the cellular regenerative microenvironment, with pro-regenerative
fibroblast numbers and the numbers of BECs remaining constant
following inhibition. Our data demonstrate that it is possible to
pharmacologically uncouple regeneration from scar fomation in
the diseased bile duct and suggest that inhibition of Wnt-ligand
production should be considered as a therapy in chronic biliary
diseases.
Methods
Mouse models. All mice were maintained in 12-h light/dark cycles and had access
to food and water ad libitum in accordance with UK Home Office Regulations. All
experiments were performed under UK Home Office licence PPL: 70/8150 held by
Dr Luke Boulter; mice were euthanised by an escalating dose of CO2. Animal
experiments were approved by the University of Edinburgh Animal Welfare Ethical
Review Board (AWERB).
For the DDC mouse model, 6–8-week-old, male CD1 mice were fed 0.1% 5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC) in their diet for up to 14 days and
provided with normal drinking water. Mice that drop >20% of their bodyweight
were given DDC food softened with water. For the TAA model, mice were given
400 mg/L thioacetamide in sweetened water for up to 12 weeks. Thioacetamide
water was present throughout the model and mice would access this ad libitum. In
studies where mice received the Porcupine inhibitor, LGK974 experimental mice
were dosed with 5 mg/kg LGK974, twice daily via oral gavage (the vehicle for this
was 0.5% methylcellulose and 0.5% Tween-80 in dH2O). Mice were dosed for 48 h
prior to the administration of DDC to ensure inhibited Wnt-ligand production
prior to injury. Effectiveness of LGK974 was confirmed through reduction of GS
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staining adjacent to central veins and is known to be Wnt-ligand dependent.
Finally, to generate livers that overexpressed β-cateninNF90, we used a
hydrodynamic model in which 20 μg of pT3-EF1aH N90-beta-catenin (a gift from
Xin Chen (Addgene plasmid # 86499; http://n2t.net/addgene:86499; RRID:
Addgene_86499)) was co-injected with 6 μg of PT2/C-Luc//PGK-SB13 (a gift from
John Ohlfest (Addgene plasmid # 20207; http://n2t.net/addgene:20207; RRID:
Addgene_20207)). These plasmids were delivered in 10% w/v physiological saline
in <7 s.
Vangl2eGFP mice were provided by Dr Ping Chen, Emory University, USA, and
were maintained on a CD1 background. Looptail mice (Vangl2S464N, Harwell, UK
and provided by Dr Charlotte Dean) were maintained on a C3H background, and
throughout these studies, wild-type littermates served as a control. Krt19CreERT:
R26RtdTomato:Vangl2flox/flox mice were generated by crossing the Krt19CreERT
mouse line initially with the tdTomato Ai14 line from Jax labs. Mice heterozygous
for the K-19CreERT knock-in and homozygous for tdTomato were then crossed
with Vangl2flox mice, which were generated and kindly provided by Prof
Deborah Henderson, Newcastle. In this study, all Krt19CreERT:R26RtdTomato:
Vangl2flox/flox mice were positive for tdTomato and CreERT and were then
homozygous, heterozygous or wild type for the Vangl2flox allele. Induction of Cre
was achieved through repeat administration of tamoxifen (three times for 1 week)
at a concentration of 4 mg per mouse for each injection. Tamoxifen was diluted in
10% molecular-grade ethanol: 90% corn oil. LysMCre:Wnt5aflox/flox mice were
generated by crossing the LysMCre line kindly provided by Dr Steven Jenkins,
University of Edinburgh, with Wnt5aflox/flox mice purchased from Jax labs. Mice
were maintained as Cre positive and homozygous, heterozygous or wild type for
the floxed allele. All genetically engineered mice were genotyped by Transnetyx Inc.
Human tissue. Five-micrometre unstained sections of formalin-fixed paraffin-
embedded explant fibrotic human liver from the deep right lobe of native explants
from patients with primary sclerosing cholangitis undergoing allograft liver
transplantation were received. Explant livers were received fresh on ice and fixed
immediately by the installation of 4% v/v neutral buffered formalin (Genta Med-
ical, UK) via the hepatic veins as part of the standard specimen pathway. Human
tissue was obtained by approved application to the Lothian NRS Human Anno-
tated Bioresource that is authorised to provide unconsented anonymised tissue
under ethical approval number 15/ES/0094 from the East of Scotland Research
Ethics Service REC 1. Informed consent was waived due to the historical nature of
these samples.
RNA isolation and RT-PCR: RNA was isolated from both tissue and organoids
by using a modified Trizol Method. Briefly, tissue was homogenized in Trizol and
RNA collected from the aqueous phase following chloroform extraction. RNA was
precipitated from the aqueous phase by using isopropanol. Precipitated RNA was
applied to an RNeasy Mini Spin Column (Qiagen) and the manufacturer’s protocol
was followed. RNA was suspended in RNAse/DNAse-free H2O and quantified
using a Nanodrop (Thermofisher). In all, 1 µg of total RNA was treated with gDNA
wipe-out buffer (Qiagen) and reverse transcribed using the Quantitect reverse
transcription kit (Qiagen) as per the manufacturer’s instructions. For quantitative
PCR ~20 ng of total cDNA was used per reaction and was run using FastStart
SYBR Green reagent (Roche), cycle conditions were defined by the manufacturer’s
protocol. All qRT-PCR reactions were run using a Lightcycler 480-II. All primer
sets used in this study were purchased from Qiagen (Table 1).
Tissue fixation and immunohistochemistry. Following euthanasia, livers were
flushed through with 20 ml of physiological saline. Dissected liver lobes were then
fixed overnight in 10% neutral buffered formalin in PBS. Following fixation, tissue
was dehydrated in 70% ethanol and processed to wax using a tissue processor.
Four-micrometre tissue sections were cut and rehydrated through graduated
alcohols. Tissue sections were antigen retrieved as per Table 2. For DAB staining of
antigens, tissue sections were treated with 10% H2O2, washed, and then native
streptavidin and biotin were blocked by using a commercial avidin and biotin
blocking kit. Following this, sections were blocked with a universal protein block.
Tissue sections were incubated overnight with primary antibodies diluted in
antibody diluent. Following washing, biotin-conjugated secondary antibodies were
incubated with tissue sections as per Table 2. Sections were further incubated with
ABC vectorstain and colour was developed using DAB substrate. For tyramide-
stained sections, the avidin/biotin step was omitted, and HRP-conjugated sec-
ondary antibodies and Alexa 488 or Alexa 594-conjugated tyramide was used as
per the manufacturer’s instructions. For directly conjugated immunofluorescent
antibodies, the same protocol was performed, by omitting the H2O2 and Avidin/
Biotin blocking stage. DAB-stained sections were imaged on an Olympus Dotslide,
Hamamatzu Nanozoomer or an Olympus BX53 upright microscope. Immuno-
fluorescence was imaged using a Nikon A1R confocal microscope.
RNAScope. RNAscope was performed on formalin-fixed liver tissue. Four-
micrometre sections were used throughout, and all RNAScope performed in this
study was done by Aquila Histoplex, Edinburgh, with the exception of Axin2,
which was performed at the core histology facility, The Beatson Institute, Glasgow.
Bile duct isolation. To isolate bile ducts from both uninjured and injured livers,
dissected liver was chopped into 5-mm3 pieces and digested in DMEM/F-12 media
containing Collagenase-IV (Roche) and DNASe-I (Roche). Following digestion and
dissociation, bile ducts become obvious as parenchyma is digested away. Bile ducts
are strained through a 70-µm filter and extensively washed in PBS to remove any
residual cells. Bile ducts are then used for downstream applications.
Organoid culture. Liver organoids were derived from isolated bile ducts. Briefly,
isolated bile ducts were resuspended in 100% GFR Matrigel. Within 24 h, bile ducts
form closed structures, and within 48 h budding can be seen from the duct. Fol-
lowing expansion, these ducts were removed from Matrigel by incubating with ice-
cold Versene. Organoids were dissociated with pipetting and then re-plated in fresh
100% Matrigel. This process was repeated to expand organoids. The growth
medium used in this study consisted of a base media of DMEM/F-12 supplemented
with Glutamax, Penicillin/Streptomycin, Fungizone and HEPES. Just prior to
feeding, the base media was supplemented with HGF, EGF, FGF10, Gastrin,
Nicotinamide, N-Acetylcystine, B-27, Forskolin, Y-27632 (ROCK inhibitor),
A83-01 (TGF-β inhibitor) and Chir99021 (GSK3β inhibitor).
To evaluate the effects of Vangl2 knockout on bile duct organoids (Vangl2flox/flox)
versus control organoids (Vangl2WT/WT) Cre was expressed from the CMV
promoter, in vitro, by infection of organoid structures with Lv-CMV-Cre (University
of Edinburgh, SuRF facility) at an MOI of 5. For infection media was supplemented
with 1/100 of Transdux reagent. For assays in which signalling was monitored in
response to genotype, growth media was withdrawn from organoid cultures, and
organoids were cultured in base media containing B-27, Forskolin, Nicotinamide and
N-Acetylcystine alone for 48 h, at which point organoids were lysed for analysis.
The non-immortalised human cholangiocyte line (NHC-3 cells) was provided
by Dr Jesus Banales (San Sebastián, Spain). Cells were grown in DMEM/F-
12 supplemented with 5% FCS, 1× MEM non-essential amino acids, 1× Lipid
mixture (chemically defined), 1× MEM vitamin solution, 1× Penicillin/
Streptomycin, 25 mg Soybean Trypsin Inhibitor, 1× Insulin/Transferrin/Selenium,
13.4 μg/ml Bovine Pituitary Extract, 3.93 μg/ml Dexamethasone, 3.4 μg/ml T3
(3,3,5-triiodo-L-thyronine), 0.025 μg/ml EGF and 4 μg/ml Forskolin, and were pH
adjusted with 3.4 N NaOH.
Preparation of bone marrow-derived macrophages. Total bone marrow was
isolated from adult mouse femurs and grown in DMEM/Ham’s F-12 media con-
taining glutamine, 10% FCS, Penicillin/Streptomycin and 50 ng/ml recombinant
MCSF in low-attachment flasks. After 48 h, the concentration of MCSF was
reduced to 25 ng/ml, and cells were maintained in this media for five further days.
Following differentiation, bone marrow- derived macrophages (BMDMs) were
plated at 1 × 103 cm−2 and left to activate for 48 h, at which point they were used
experimentally.
FACS isolation of hepatic macrophages. Dissected livers were minced and then
digested for 2 h in DMEM/F-12 nutrient culture media containing 1% of FCS,
0.5 mg/ml Collagenase, 0.5 mg/ml Dispase and 0.1 mg/ml DNase1. Following
digestion, liver tissue was mashed through a 70-μm cell strainer. Heptocytes and
large cell clumps were removed from the cell mixture by slow speed centrifugation
at 50 × g. The remaining cells were then pelleted and red cells lysed using Red Cell
Lysis buffer (Gibco). Following lysis, cells were blocked in PBS containing BSA and
sodium azide for 30 min on ice. Following blocking, cells were incubated in
blocking buffer with CD45-PE and CD11b-PECy7 (Biolegend) antibodies for 1 h at
room temperature and were then sorted using a FACS Aria II. Dead cells were
excluded from sorting using DAPI.
Table 1 qPCR primers used in this study.
Provider Catalogue number
Mouse
Axin2 Qiagen QT00126539
Ccnd1 Qiagen QT00154595
Ctgf Qiagen QT00096131
Lef1 Qiagen QT00148834
Mmp7 Qiagen QT00110012
Myc Qiagen QT00096194
Ppia Qiagen QT00247709
Ptk7 Qiagen QT00144032
Vangl1 Qiagen QT00494235
Vangl2 Qiagen QT00128422
Wnt5a Qiagen QT00164500
Human
PPIA Qiagen QT00052311
VANGL1 SAbiosciences PPH21116A
VANGL2 SAbiosciences PPH12377B
WNT5A SAbiosciences PPH02410A
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Western blotting. Isolated bile ducts or organoids were lysed in RIPA buffer
containing phosphatase (Thermo Fisher) and protease (MiniComplete, Roche)
inhibitors. Protein quantification was determined using Pierce BCA reagent
(Pierce) and quantified using a nanodrop. The standard curve for protein quan-
tification was derived from the BCA reagent handbook using Albumin standards
provided. In all, 20 μg of total protein was loaded onto a 4–12% NuPage Bis-Tris
gel (Thermo Fisher). Prior to running, proteins were reduced with NuPage LDS
sample buffer (4×) and NuPage Sample Reducing Agent (10×). All gels were run
using NuPage MOPS SDS Running buffer containing NuPage Antioxidant. Pro-
teins were transferred onto PVDF membrane (Amersham) using NuPage Transfer
Buffer. Following transfer, membranes were blocked in either 5% BSA (Sigma
Aldrich) in TBST or 5% dried milk (Marvel) in TBST. Membranes were incubated
with primary antibodies (Table 2) at 4 °C overnight. Following washing with TBST,
membranes were incubated with HRP-conjugated secondary antibodies (Table 2)
at room temperature for 1 h. Following washing the signal was developed using
ECL (Pierce). Uncropped images of gels are available in the source data file.
Plasmid preparation. Both the pT3-EF1aH N90-beta-catenin and PT2/C-Luc//
PGK-SB13 plasmids were grown in LB media, containing 100 μg/ml ampicillin
overnight. Cells were pelleted and plasmids were prepared with a Qiagen
endotoxin-free maxiprep kit, as per the manufacturer’s instructions. Plasmid
concentration was determined using a Nanodrop.
Image analysis. Image analysis was conducted using ImageJ and macros written
by Dr Tim J Kendall. Macros are available on request.
Statistics. All experimental groups were analysed for normality using a
D’Agostino–Pearson Omnibus test. Groups that were normally distributed
were compared with either a two-tailed Student’s t test (for analysis of two
groups) or using one-way ANOVA to compare multiple groups, with a post
hoc correction for multiple testing. Non-parametric data were analysed
using a Wilcoxon–Mann–Whitney U test when comparing two groups
or a Kruskall–Wallis test when comparing multiple non-parametric data.
Throughout p < 0.05 was considered significant. Data are represented as mean
with S.E.M. for parametric data or median with S.D. for non-parametric data.
Study approval. All animal experiments were approved by the University
of Edinburgh local ethics committee and were licensed by the UK Home
Office. All patient material contained in this paper was approved by the NHS
Lothian Bio resource ethics committee. No prospective tissue was collected in
this study.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the findings of this study are available
within the paper and its supplementary information files. The source data underlying
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3a, f, 4a, d, e, h, 5a and 6b, c are provided as a Source Data file.
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Table 2 Antibodies used in this study.
Provider Catalogue number Conditions
Primary antibodies
Alpha smooth muscle actin (1A4) Sigma Aldrich A2547 15 m Citrate. 1/2000 dilution O/N
β-actin Cell Signalling Technologies 8457P 1/5000O/N (western blot)
β-catenin BD Transduction Laboratories 610154 1 h Citrate 1/50 O/N
Calnexin Enzo ADI-SPA-860-D 1/2000 O/N
CD45-PE BioLegend 103105 1 µl per 1 × 10e6 cells, 30m RT
CD11b-PECy7 BioLegend 101215 1 µl per 1 × 10e6 cells, 30m RT
CD68 (KP1) Dako M081401-2
c-JUN (total) (60A8) Cell Signalling Technologies 9165 30m Citrate. 1/100 dilution O/N 1/1000O/N
(western blot)
Collagen-1 Southern Biotech 1310-01 5m Citrate. 2/200 dilution 72 h
Ctgf Abcam ab6992 No antigen retrival 1/100 O/N
Desmin (Y66) Abcam Ab32362 15 m Citrate. 1/100 dilution O/N
E-cadherin DECMA-1 Genetex GTX11512 1/100O/N
GFP Abcam ab13970 5m Tris-EDTA. 1/500 O/N
Glutamine Synthatase Abcam ab64613 10m Citrate 1/100
Keratin-19 (TROMA-III) Developmental Studies
Hybridoma Bank
Troma-III 10m Citrate. 1/200 dilution O/N
pcJUN (ser73) (D47G9) Cell Signalling Technologies 3270 30m Citrate. 1/100 dilution O/N
pcJUN (ser63) (54B3)
(western blot)
Cell Signalling Technologies 2361 1/1000 O/N
JNK (total) Cell Signalling Technologies 9252 30m Citrate. 1/100 dilution O/N 1/1000O/N
(western blot)
pJNK (Thr183/Tyr185) (81E11) Cell Signalling Technologies 4668 30m Citrate. 1/100 dilution O/N
PTK7 Source Bioscience LS-B10725 10m Tris-EDTA 1/100 O/N
RFP Abcam ab62341 10m Citrate. 1/100 dilution O/N
Vangl1 Sigma Aldrich HPA025235 10m Tris-EDTA 1/100 O/N
Vangl2 Sigma Aldrich HPA027043 10m Tris-EDTA 1/100 O/N
Vangl2 (western blot) R&D Systems AF4815 1/500 O/N
Wnt5a LS Bio LS-B4565 10m Tris-EDTA 1/100 O/N
Secondary antibodies
Anti-goat Alexa 594 Thermo Fisher A-27016 1/500 1 h RT
Anti-goat Biotinylated Vector Laboratories BA-5000 1/500 1 h RT
Anti-mouse Alexa 488 Thermo Fisher A32723 1/500 1 h RT
Anti-rabbit Alexa 594 Thermo Fisher A-21207 1/500 1 h RT
Anti-Rabbit Biotinylated Vector Laboratories BA-1000 1/500 1 h RT
Anti-rabbit HRP Vector Laboratories PI-1000 1/500 1 h RT
Anti-rat Alexa 488 Thermo Fisher A-21208 1/500 1 h RT
Anti-rat Alexa 594 Thermo Fisher A-21209 1/500 1 h RT
Tyramide Alexa 594 Thermo Fisher B40957 1/50 10m RT
Tyramide Alexa 488 Thermo Fisher B40953 1/50 10m RT
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